HIV-Associated Sensory Impairment: Eyes and Ears
HIV can affect sensory organs directly (viral infection, immune-mediated) and indirectly (opportunistic infections, drug toxicity, vascular). Regular screening is essential for early intervention.
Ocular Manifestations
HIV-Associated Retinopathy (Microvasculopathy)
- Most common (40–60% in untreated); cotton-wool spots, hemorrhages, microaneurysms.
- Usually asymptomatic; reflects systemic microvascular disease.
CMV Retinitis (AIDS-Defining)
- Occurs at CD4 <50; painless floaters, flashes, field loss.
- Sight-threatening; requires urgent intravitreal/systemic valganciclovir, foscarnet, cidofovir.
- Immune recovery uveitis (IRU) after ART initiation.
Other Ocular OIs
- HSV/VZV: acute retinal necrosis (ARN), keratitis
- Toxoplasma: chorioretinitis
- Syphilis: posterior uveitis, optic neuritis
- TB: choroidal tubercles
- Cryptococcal: optic neuritis, papilledema
Neoplastic
- Kaposi sarcoma: conjunctival/eyelid lesions
- Primary CNS lymphoma: vitreoretinal involvement
Drug Toxicity
- Cidofovir: ocular hypotony, uveitis
- Rifabutin: uveitis
- Chloroquine/hydroxychloroquine: retinopathy (rare at HIV doses)
Auditory / Vestibular Manifestations
Sensorineural Hearing Loss (SNHL)
- Prevalence 20–40% in HIV+ adults; multifactorial.
- Mechanisms: direct viral infection of cochlea/CN VIII, microvascular ischemia, mitochondrial toxicity (NRTIs — ddI, d4T, AZT), OIs (TB meningitis, cryptococcal meningitis), immune-mediated.
- Often bilateral, high-frequency, progressive.
Vestibular Dysfunction
- CN VIII involvement → vertigo, imbalance, oscillopsia.
- Causes: HIV encephalopathy, OIs (toxoplasmosis, lymphoma), drug toxicity (aminoglycosides for MAC/TB).
Otitis Media / Externa
- Increased frequency/severity with low CD4; Pseudomonas, Aspergillus, TB.
Screening Recommendations
- Ophthalmology: Baseline dilated fundus exam at diagnosis; annually if CD4 >200; q3–6mo if CD4 <200 or on specific drugs. Urgent if visual symptoms.
- Audiology: Baseline audiogram; repeat if symptoms, ototoxic drugs, or CD4 decline. Vestibular testing if dizziness.
- Patient education: Report floaters, vision loss, hearing changes, dizziness immediately.
With ART and immune recovery, many HIV-related sensory complications have declined, but vigilance remains key—especially in late presenters.
HIV & AIDS - Related Articles
- AIDS: Synonyms, Terminology & Related Terms
- HIV and Pancreatic Health: Understanding the Risks
- HIV Test Result Timelines: Rapid vs. Standard Tests
- HIV & AIDS: How HIV Destroys CD4+ T Cells
- HIV & AIDS for Teens: Understanding Transmission & Prevention
- HIV and Pregnancy: Transmission Risks and Prevention
- HIV Transmission Risk Through Tears: What You Need to Know
